Microsoft has ended support for its pre-IE11 browsers as of January 2016 and will be discontinuing IE11 support in August 2021.

If you are seeing this message, you are viewing the site on one of these unsupported browsers. We only support the recent versions of major browsers such as Chrome, Firefox, Safari, and Edge.

Thank you.

(click to close and continue using this browser)

contact privacy policy profile Search log in


The SUO-CTC overarching objective is to assist in the development of clinical trials in patients with urologic cancers and to participate in the conduct of network clinical trials involving therapeutic, diagnostic or prognostic procedures.  
In support of our efforts the SUO-CTC offers national access to:

  • Key patient populations
  • Physician thought leaders
  • Clinical-research expertise
  • Best practice methodology 

Following detailed discussion of the protocol and project needs and objectives, services are customized to the individual project requirements and include but are not limited to:

  • Protocol Project Management — includes administrative costs throughout the conduct of the study
    • Protocol review for scientific merit and operational viability
    • Site surveys/Feasibility Questionnaires
    • Call for sites and site selection via a secure website
    • Investigator and site communications
    • Protocol/project education
    • Patient recruitment and referral initiatives
    • Investigator meetings
    • Protocol updates to SUO membership at large via meetings, newsletters, website
    • Abstract and Manuscript preparation/publication
  • Consultancy Agreements — includes Board of Director and Member consultation on the science of the protocol and logistics of the project
    • Protocol design and development for CTC participation
    • Project operations
    • Advisory boards